Cargando…
The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
The synergy of radiation and the immune system is currently receiving significant attention in oncology as numerous studies have shown that cancer irradiation can induce strong anti-tumor immune responses. It remains unclear, however, what are the best radiation fractionation protocols to maximize t...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275030/ https://www.ncbi.nlm.nih.gov/pubmed/30380596 http://dx.doi.org/10.3390/ijms19113377 |
_version_ | 1783377745552605184 |
---|---|
author | Poleszczuk, Jan Enderling, Heiko |
author_facet | Poleszczuk, Jan Enderling, Heiko |
author_sort | Poleszczuk, Jan |
collection | PubMed |
description | The synergy of radiation and the immune system is currently receiving significant attention in oncology as numerous studies have shown that cancer irradiation can induce strong anti-tumor immune responses. It remains unclear, however, what are the best radiation fractionation protocols to maximize the therapeutic benefits of this synergy. Here, we present a novel mathematical model that can be used to predict and dissect the complexity of the immune-mediated response at multiple tumor sites after applying focal irradiation and systemic immunotherapy. We successfully calibrate the proposed framework with published experimental data, in which two tumors were grown in mice at two spatially-separated sites from which only one was irradiated using various radiation fractionation protocols with and without concurrent systemic immunotherapy. The proposed model is calibrated to fit the temporal dynamics of tumor volume at both sites and can predict changes in immune infiltration in the non-irradiated tumors. The model was then used to investigate additional radiation fractionation protocols. Model simulations suggest that the optimal radiation doses per fraction to maximize anti-tumor immunity are between 10 and 13 Gy, at least for the experimental setting used for model calibration. This work provides the framework for evaluating radiation fractionation protocols for radiation-induced immune-mediated systemic anti-tumor responses. |
format | Online Article Text |
id | pubmed-6275030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62750302018-12-15 The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity Poleszczuk, Jan Enderling, Heiko Int J Mol Sci Article The synergy of radiation and the immune system is currently receiving significant attention in oncology as numerous studies have shown that cancer irradiation can induce strong anti-tumor immune responses. It remains unclear, however, what are the best radiation fractionation protocols to maximize the therapeutic benefits of this synergy. Here, we present a novel mathematical model that can be used to predict and dissect the complexity of the immune-mediated response at multiple tumor sites after applying focal irradiation and systemic immunotherapy. We successfully calibrate the proposed framework with published experimental data, in which two tumors were grown in mice at two spatially-separated sites from which only one was irradiated using various radiation fractionation protocols with and without concurrent systemic immunotherapy. The proposed model is calibrated to fit the temporal dynamics of tumor volume at both sites and can predict changes in immune infiltration in the non-irradiated tumors. The model was then used to investigate additional radiation fractionation protocols. Model simulations suggest that the optimal radiation doses per fraction to maximize anti-tumor immunity are between 10 and 13 Gy, at least for the experimental setting used for model calibration. This work provides the framework for evaluating radiation fractionation protocols for radiation-induced immune-mediated systemic anti-tumor responses. MDPI 2018-10-29 /pmc/articles/PMC6275030/ /pubmed/30380596 http://dx.doi.org/10.3390/ijms19113377 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Poleszczuk, Jan Enderling, Heiko The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity |
title | The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity |
title_full | The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity |
title_fullStr | The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity |
title_full_unstemmed | The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity |
title_short | The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity |
title_sort | optimal radiation dose to induce robust systemic anti-tumor immunity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275030/ https://www.ncbi.nlm.nih.gov/pubmed/30380596 http://dx.doi.org/10.3390/ijms19113377 |
work_keys_str_mv | AT poleszczukjan theoptimalradiationdosetoinducerobustsystemicantitumorimmunity AT enderlingheiko theoptimalradiationdosetoinducerobustsystemicantitumorimmunity AT poleszczukjan optimalradiationdosetoinducerobustsystemicantitumorimmunity AT enderlingheiko optimalradiationdosetoinducerobustsystemicantitumorimmunity |